Newron Pharmaceuticals SpA Financial Flexibility Index
Newron Pharmaceuticals SpA financial flexibility index. Newron Pharmaceuticals SpA (NWRN) has a Financial Flexibility Index of -0.03x as of December 2025. Free cash flow of CHF-1.31 Million (operating CF CHF-1.33 Million minus capex CHF15.73K) represents 0% of total liabilities (CHF51.15 Million). See Newron Pharmaceuticals SpA free cash flow generation to measure how efficiently the company converts operating cash flow to free cash.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Financial Flexibility Index of Newron Pharmaceuticals SpA (2005–2025)
Financial flexibility index of Newron Pharmaceuticals SpA from 2005 to 2025. Historical Financial Flexibility Index trend for Newron Pharmaceuticals SpA across 21 annual periods. Check how high is Newron Pharmaceuticals SpA's earnings quality to evaluate the quality of earnings relative to operating cash generation.
Newron Pharmaceuticals SpA Financial Flexibility Index by Year (2005–2025)
Newron Pharmaceuticals SpA financial flexibility index by year from 2005 to 2025. Year-by-year free cash flow to debt coverage for Newron Pharmaceuticals SpA. For the full cash flow conversion analysis, see Newron Pharmaceuticals SpA operating cash flow efficiency.
| Year | Flexibility Index | Free Cash Flow (CHF) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.64x | CHF32.61 Million | CHF32.56 Million | CHF51.15 Million | ▲ +326.2% |
| 2024 | -0.28x | CHF-17.60 Million | CHF-17.61 Million | CHF62.45 Million | ▼ -55.2% |
| 2023 | -0.18x | CHF-10.13 Million | CHF-10.14 Million | CHF55.77 Million | ▲ +16.0% |
| 2022 | -0.22x | CHF-11.07 Million | CHF-11.09 Million | CHF51.23 Million | ▲ +10.3% |
| 2021 | -0.24x | CHF-11.43 Million | CHF-11.45 Million | CHF47.38 Million | ▲ +47.4% |
| 2020 | -0.46x | CHF-15.55 Million | CHF-15.59 Million | CHF33.95 Million | ▲ +50.9% |
| 2019 | -0.93x | CHF-21.93 Million | CHF-21.98 Million | CHF23.49 Million | ▲ +69.7% |
| 2018 | -3.08x | CHF-15.92 Million | CHF-15.95 Million | CHF5.16 Million | ▼ -95.1% |
| 2017 | -1.58x | CHF-8.38 Million | CHF-8.40 Million | CHF5.30 Million | ▲ +44.6% |
| 2016 | -2.85x | CHF-19.51 Million | CHF-19.58 Million | CHF6.84 Million | ▼ -61.9% |
| 2015 | -1.76x | CHF-12.80 Million | CHF-12.86 Million | CHF7.27 Million | ▼ -37.9% |
| 2014 | -1.28x | CHF-9.98 Million | CHF-10.00 Million | CHF7.81 Million | ▼ -26.8% |
| 2013 | -1.01x | CHF-10.61 Million | CHF-10.69 Million | CHF10.53 Million | ▼ -394.2% |
| 2012 | 0.34x | CHF5.84 Million | CHF5.83 Million | CHF17.04 Million | ▲ +148.4% |
| 2011 | -0.71x | CHF-4.94 Million | CHF-4.94 Million | CHF6.98 Million | ▲ +74.3% |
| 2010 | -2.75x | CHF-19.12 Million | CHF-19.13 Million | CHF6.94 Million | ▼ -48.5% |
| 2009 | -1.85x | CHF-22.99 Million | CHF-23.06 Million | CHF12.39 Million | ▼ -39.6% |
| 2008 | -1.33x | CHF-19.57 Million | CHF-19.93 Million | CHF14.73 Million | ▼ -27.4% |
| 2007 | -1.04x | CHF-13.53 Million | CHF-13.87 Million | CHF12.97 Million | ▼ -99.3% |
| 2006 | -0.52x | CHF-9.58 Million | CHF-9.63 Million | CHF18.30 Million | ▲ +76.2% |
| 2005 | -2.20x | CHF-14.23 Million | CHF-14.33 Million | CHF6.48 Million | — |